Literature DB >> 11733566

Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings.

I Bronsveld1, F Mekus, J Bijman, M Ballmann, H R de Jonge, U Laabs, D J Halley, H Ellemunter, G Mastella, S Thomas, H J Veeze, B Tümmler.   

Abstract

To investigate the impact of chloride (Cl(-)) permeability, mediated by residual activity of the cystic fibrosis transmembrane conductance regulator (CFTR) or by other Cl(-) channels, on the manifestations of cystic fibrosis (CF), we determined Cl(-) transport properties of the respiratory and intestinal tracts in Delta F508 homozygous twins and siblings. In the majority of patients, cAMP and/or Ca(2+)-regulated Cl(-) conductance was detected in the airways and intestine. Our finding of cAMP-mediated Cl(-) conductance suggests that, in vivo, at least some Delta F508 CFTR can reach the plasma membrane and affect Cl(-) permeability. In respiratory tissue, the expression of basal CFTR-mediated Cl(-) conductance, demonstrated by 30% of Delta F508 homozygotes, was identified as a positive predictor of milder CF disease. In intestinal tissue, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid-insensitive (DIDS-insensitive) Cl(-) secretion, which is indicative of functional CFTR channels, correlated with a milder phenotype, whereas DIDS-sensitive Cl(-) secretion was observed mainly in more severely affected patients. The more concordant Cl(-) secretory patterns within monozygous twins compared with dizygous pairs imply that genes other than CFTR significantly influence the manifestation of the basic defect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733566      PMCID: PMC200980          DOI: 10.1172/JCI12108

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion.

Authors:  S R Thomas; A Jaffe; D M Geddes; M E Hodson; E W Alton
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

2.  Efficiency of two different nine-loci short tandem repeat systems for DNA typing purposes.

Authors:  L Sacchetti; G Calcagno; I Coto; N Tinto; E Vuttariello; F Salvatore
Journal:  Clin Chem       Date:  1999-02       Impact factor: 8.327

3.  Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development.

Authors:  A Prader; R H Largo; L Molinari; C Issler
Journal:  Helv Paediatr Acta Suppl       Date:  1989-06

4.  Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics.

Authors:  F Mekus; M Ballmann; I Bronsveld; J Bijman; H Veeze; B Tümmler
Journal:  Twin Res       Date:  2000-12

5.  Changes in the normal maximal expiratory flow-volume curve with growth and aging.

Authors:  R J Knudson; M D Lebowitz; C J Holberg; B Burrows
Journal:  Am Rev Respir Dis       Date:  1983-06

6.  Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis.

Authors:  J Navarro; M Rainisio; H K Harms; M E Hodson; C Koch; G Mastella; B Strandvik; S G McKenzie
Journal:  Eur Respir J       Date:  2001-08       Impact factor: 16.671

7.  Mechanism of chloride secretion induced by carbachol in a colonic epithelial cell line.

Authors:  K Dharmsathaphorn; S J Pandol
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

8.  The secretory actions of histamine in rat small intestine.

Authors:  J Hardcastle; P T Hardcastle
Journal:  J Physiol       Date:  1987-07       Impact factor: 5.182

9.  Forskolin stimulates adenylate cyclase in human colonic crypts: interaction with VIP.

Authors:  N Boige; B Amiranoff; A Munck; M Laburthe
Journal:  Eur J Pharmacol       Date:  1984-05-18       Impact factor: 4.432

10.  Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.

Authors:  M Knowles; J Gatzy; R Boucher
Journal:  N Engl J Med       Date:  1981-12-17       Impact factor: 91.245

View more
  44 in total

1.  Ulcerative colitis patients in remission have an altered secretory capacity in the proximal colon despite macroscopically normal mucosa.

Authors:  J K Gustafsson; G C Hansson; H Sjövall
Journal:  Neurogastroenterol Motil       Date:  2012-06-24       Impact factor: 3.598

Review 2.  Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.

Authors:  Thomas J Jentsch; Tanja Maritzen; Anselm A Zdebik
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 3.  Cystic fibrosis modifier genes.

Authors:  Jane Davies; Eric Alton; Uta Griesenbach
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

4.  COX-2: a link between airway inflammation and disordered chloride secretion in cystic fibrosis?

Authors:  A Clayton; A J Knox
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

5.  Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.

Authors:  Silvia M Kreda; Marcus Mall; April Mengos; Lori Rochelle; James Yankaskas; John R Riordan; Richard C Boucher
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

6.  Initial interrogation, confirmation and fine mapping of modifying genes: STAT3, IL1B and IFNGR1 determine cystic fibrosis disease manifestation.

Authors:  Heike Labenski; Silke Hedtfeld; Tim Becker; Burkhard Tümmler; Frauke Stanke
Journal:  Eur J Hum Genet       Date:  2011-07-06       Impact factor: 4.246

7.  Regulatory domain phosphorylation to distinguish the mechanistic basis underlying acute CFTR modulators.

Authors:  Louise C Pyle; Annette Ehrhardt; Lisa High Mitchell; Lijuan Fan; Aixia Ren; Anjaparavanda P Naren; Yao Li; J P Clancy; Graeme B Bolger; Eric J Sorscher; Steven M Rowe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-01       Impact factor: 5.464

8.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

9.  Clinical and molecular characterization of S1118F-CFTR.

Authors:  Himabindu Penmatsa; Carla A Frederick; Sunitha Nekkalapu; Veronica G Conoley; Weiqiang Zhang; Chunying Li; John Kappes; Dennis C Stokes; Anjaparavanda P Naren
Journal:  Pediatr Pulmonol       Date:  2009-10

Review 10.  [Molecular genetics principles in cystic fibrosis. An example of genetic illness in pneumology].

Authors:  B Tümmler; M Stuhrmann
Journal:  Internist (Berl)       Date:  2003-06       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.